It indicates that CEACAM1 may be a key factor linking COPD and lung cancer, and the regulation of CEACAM1-S and -L isoforms may be a therapeutic target for COPD-lung cancer transit. This evidence concerns the gene CEACAM1 and chronic obstructive pulmonary disease.